Related Articles
Dose-escalation phase I study in metastatic breast cancer patients with combination of paclitaxel and tegafur·uracil
Experimental postoperative adjuvant chemotherapy by UFT using primary tumor amputation model.
Phase II study on low dose gemcitabine plus oral chemotherapy with uracil-tegafur and cyclophosphamide in combination with radiotherapy against recurrent and advanced pancreatic cancer
Cyclophosphamide augments the anti-tumor efficacy of uracil and tegafur by inhibiting dihydropyrimidine dehydrogenase
Long-term survival after immunochemotherapy for juvenile colon cancer with peritoneal dissemination: a case report.